Nurix Therapeutics Inc
(NRIX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 11/30
| 02-2021 | 11-2020 | 08-2020 | 05-2020 | 02-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 126,381 | 119,356 | 265,527 | 159,329 | 0 |
| Marketable Securities | 176,692 | 161,792 | 88,716 | 14,174 | 0 |
| Receivables | 3,981 | 3,846 | 3,856 | 19,590 | 0 |
| Other current assets | 0 | 7,500 | 0 | 0 | 0 |
| TOTAL | $310,768 | $298,434 | $364,089 | $196,804 | $0 |
| Non-Current Assets | |||||
| PPE Net | 6,960 | 6,672 | 6,532 | 5,789 | N/A |
| Investments And Advances | 77,191 | 90,890 | 40,898 | 9,110 | 0 |
| Other Non-Current Assets | 1,741 | 347 | 355 | 1,574 | 0 |
| TOTAL | $85,892 | $97,909 | $47,785 | $16,473 | $N/A |
| Total Assets | $396,660 | $396,343 | $411,874 | $213,277 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,388 | 3,412 | 3,611 | 4,903 | 0 |
| Accrued Expenses | 10,833 | 8,328 | 7,102 | 4,161 | 0 |
| TOTAL | $47,972 | $44,539 | $41,012 | $34,436 | $0 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 32,751 | 32,799 | 30,299 | 25,372 | N/A |
| Other Non-Current Liabilities | 832 | 850 | 868 | 168,980 | 0 |
| TOTAL | $78,555 | $61,535 | $63,242 | $240,367 | $N/A |
| Total Liabilities | $126,527 | $106,074 | $104,254 | $274,803 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 44,347 | 38,907 | 38,855 | 37,038 | N/A |
| Common Shares | 39 | 39 | 39 | 4 | 0 |
| Retained earnings | -127,973 | -103,698 | -83,784 | -65,267 | 0 |
| Other shareholders' equity | 49 | 87 | 138 | 139 | 0 |
| TOTAL | $270,133 | $290,269 | $307,620 | $-61,526 | $0 |
| Total Liabilities And Equity | $396,660 | $396,343 | $411,874 | $213,277 | $0 |